The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1415
ISSUE 1415
April 29, 2013
Issue 1415
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Icosapent Ethyl (Vascepa) for Severe Hypertriglyceridemia
April 29, 2013 (Issue: 1415)
Icosapent ethyl (Vascepa [vas EE puh] – Amarin), the
ethyl ester of eicosapentaenoic acid (EPA), has been
approved by the FDA as an adjunct to diet for treatment of
severe hypertriglyceridemia (≥500 mg/dL). Vascepa is
the second omega-3...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.